Trial Profile
Comparison of adherence of exenatide administered once in a week versus liraglutide administered once in a day in patients with Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jun 2015
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Liraglutide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 02 Jun 2015 New trial record
- 20 May 2015 Results presented at the 20th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research.